[1]邱海峰.經尿道等離子前列腺剜除術治療前列腺增生癥的療效[J].醫學信息,2020,(04):123-124.[doi:10.3969/j.issn.1006-1959.2020.04.038]
 QIU Hai-feng.Efficacy of Transurethral Plasma Prostatectomy for Benign Prostatic Hyperplasia[J].Medical Information,2020,(04):123-124.[doi:10.3969/j.issn.1006-1959.2020.04.038]
點擊復制

經尿道等離子前列腺剜除術治療前列腺增生癥的療效()
分享到:

醫學信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期數:
2020年04期
頁碼:
123-124
欄目:
臨床研究
出版日期:
2020-02-15

文章信息/Info

Title:
Efficacy of Transurethral Plasma Prostatectomy for Benign Prostatic Hyperplasia
文章編號:
1006-1959(2020)04-0123-02
作者:
邱海峰
(佳木斯市中心醫院泌尿外科,黑龍江 佳木斯 154002)
Author(s):
QIU Hai-feng
(Department of Urology,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China)
關鍵詞:
前列腺增生癥經尿道康復效果等離子前列腺剜除術
Keywords:
Benign prostatic hyperplasiaTransurethralRehabilitation effectPlasma prostatectomy
分類號:
R699
DOI:
10.3969/j.issn.1006-1959.2020.04.038
文獻標志碼:
A
摘要:
目的 探討經尿道等離子前列腺剜除術治療前列腺增生癥的療效。方法 選取2017年9月~2019年8月我院收治的前列腺增生癥患者74例,采用隨機數表法分為實驗組和對照組,每組37例。實驗組行經尿道等離子前列腺剜除術,對照組行經尿道前列腺電切術。比較兩組術中出血量、最大尿流量、IPSS評分、術后殘余尿量、并發癥發生率及尿管留置時間。結果 實驗組并發癥發生率為0,低于對照組的10.81%,差異具有統計學意義(P<0.05);實驗組術后殘余尿量為(27.21±3.82)ml、最大尿流量為(22.43±3.71)ml/s,優于對照組的(29.92±5.58)ml、(19.25±3.16)ml/s,差異具有統計學意義(P<0.05);兩組術中出血量、留置尿管時間與前列腺切除量比較,差異具有統計學意義(P<0.05)。術后2個月,實驗組IPSS評分為(5.19±1.36)分,低于對照組的(6.52±1.74)分,差異具有統計學意義(P<0.05)。結論 經尿道等離子前列腺剜除術治療前列腺增生癥患者,可有效改善患者術中出血量、最大尿流量、IPSS評分、術后殘余尿量,且并發癥發生率低,利于患者術后康復。
Abstract:
Objective To investigate the efficacy of transurethral plasma prostate enucleation in the treatment of benign prostatic hyperplasia. Methods A total of 74 patients with benign prostatic hyperplasia treated in our hospital from September 2017 to August 2019 were selected and randomly divided into an experimental group and a control group, with 37 cases in each group. The experimental group underwent transurethral plasma prostatectomy, and the control group underwent transurethral resection of the prostate. The intraoperative blood loss, maximum urine flow, IPSS score, postoperative residual urine volume, complication rate, and urinary indwelling time were compared between the two groups.Results The complication rate in the experimental group was 0, which was lower than 10.81% in the control group,the difference was statistically significant(P<0.05). The residual urine volume in the experimental group was (27.21±3.82) ml and the maximum urine flow was(22.43±3.71) ml/s, which was better than (29.92±5.58) ml and (19.25±3.16) ml/s in the control group,the differences were statistically significant (P<0.05);The intraoperative blood loss, indwelling catheter time and prostatectomy volume were significantly different between the two groups (P<0.05). At 2 months after operation, the IPSS score of the experimental group was (5.19±1.36) points, which was lower than the control group (6.52±1.74) points,the difference was statistically significant (P<0.05).Conclusion Transurethral plasma prostatectomy for patients with benign prostatic hyperplasia can effectively improve the intraoperative blood loss, maximum urine flow, IPSS score, and residual urine volume, and the incidence of complications is low, which is conducive to postoperative recovery.

參考文獻/References:

[1]李國成.前列腺增生電切術配合同期不同碎石術治療前列腺增生合并膀胱結石的療效及對其癥狀積分、生活質量的影響[J].國際泌尿系統雜志,2019,39(5):779-782. [2]蔣茂,薛曉文,程偉,等.良性前列腺增生與前列腺慢性炎癥的相關性研究進展[J].藥學與臨床研究,2019,27(4):294-299. [3]關勝,徐皖江,蔡萬松,等.不同手術方案治療高危良性前列腺增生癥患者的療效對比研究[J].中國性科學,2019,28(8):14-18. [4]張斌斌,杜玲玲,汪峰,等.保留部分前列腺前葉等離子剜除術治療60 ml以上前列腺增生癥的尿控策略[J].中國性科學,2019,28(7):23-26.

相似文獻/References:

[1]馬志遠.TURP與TUVP治療良性前列腺增生的療效比較[J].醫學信息,2020,(07):115.[doi:10.3969/j.issn.1006-1959.2020.07.035]
 MA Zhi-yuan.Comparison of Curative Effect Between TURP and TUVP in the Treatment of Benign Prostatic Hyperplasia[J].Medical Information,2020,(04):115.[doi:10.3969/j.issn.1006-1959.2020.07.035]

更新日期/Last Update: 2020-02-15
中国足彩网竞彩 山西省十一选五走势图 江西11选五5开奖规则 北京赛车开奖直播 体彩22选5开奖结果今天晚上 腾讯五分彩龙虎计划 3d试机号 开奖 20选5开奖查询最新 dnf赌博豆豆网 幸运28 换股 河南快三推荐号码推荐